logo
Medtech firms flag inflated MRPs on imported devices

Medtech firms flag inflated MRPs on imported devices

Economic Times7 days ago
Indian manufacturers of medical devices have alleged that several private hospitals and retailers, in the chase for higher margins, are pushing sales of imported products, some of which carry inflated price tags or do not mention the maximum retail price (MRP). These imported devices of established brands account for about 65% of the medical devices sold in India, according to industry sources.The matter was discussed at a recent meeting with commerce and industry minister Piyush Goyal, industry executives told ET."It has been seen that the private hospitals and retailers preferentially push imported medical devices, often labelled with inflated or absent MRPs," a senior industry executive who attended the meeting told ET. "The hospitals are doing this to earn higher trade margins compared to affordable Indian made devices." The executive did not wish to be named.At the meeting, representatives of domestic manufacturers discussed the procurement challenges the industry is facing in this regard.
"They are making higher margins and more money. The consumer would bear the brunt and, hence, this issue was discussed during the meeting. The ministry has asked the NPPA (National Pharmaceutical Pricing Authority) to look into the matter," said another executive, requesting not to be named.
Rajiv Nath, forum coordinator of Association of Indian Medical Device Industry (AiMeD), said domestic manufacturers face a stiff challenge in the market from imported devices despite offering the same product at rates that are 20-40% less, "as private hospitals and retailers are preferentially pushing imported established brands of medical devices, often carrying inflated prices or at times labels even without MRPs"."Indian manufacturers are forced to hike their labelled MRP to satisfy these buyers," he said.Nath said domestic manufacturers have demanded that all import e-bills of lading should capture the import landed price as well as the MRP on the medical device, and any irrationally excessive MRP of 20 to 30 times of landed cost should be flagged for investigation for duty evasion and unfair trade practices.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Trump's 50% tariffs fail to hit $30 bn of Indian exports: Pharma, smartphones exempted
Trump's 50% tariffs fail to hit $30 bn of Indian exports: Pharma, smartphones exempted

First Post

time4 minutes ago

  • First Post

Trump's 50% tariffs fail to hit $30 bn of Indian exports: Pharma, smartphones exempted

Despite US President Donald Trump's decision to double tariffs on Indian goods to 50% from August 6, a major chunk of Indian exports worth nearly $30 billion remains untouched for now. Key sectors like pharmaceuticals and electronics including smartphones and semiconductors continue to enjoy exemptions under a carve-out list that shields them from higher duties. The tariff hike, justified by the Trump administration as a response to India's continued procurement of Russian energy and arms is expected to impact India's labour-intensive export segments. However, shipments of critical products such as medicines, mobile phones and energy supplies have been spared at least for the moment. STORY CONTINUES BELOW THIS AD In FY25, India exported pharmaceuticals and electronics worth $10.5 billion and $14.6 billion respectively to the US, together accounting for over 29% of its total exports to America which stood at $86.5 billion. Interestingly, India's petroleum exports amounting to $4.09 billion have also been excluded from the latest tariffs due to their placement in the energy exemption list. These high-value categories had previously escaped the initial 25% tariff announced on July 30 as well. While these exemptions offer temporary relief, uncertainty remains. Trump has warned of tariffs going as high as 250% on foreign-manufactured pharmaceuticals and the status of smartphones may shift depending on future policy decisions. The executive order signed on August 6 clarified that all goods currently listed under exemptions would continue to receive preferential access to the US market at lower or zero tariffs. The original 25% tariff was introduced after talks to finalise a limited trade deal between the two countries collapsed. That move, which takes effect on August 7, paved the way for this latest escalation. India and the US are still working towards concluding a broader Bilateral Trade Agreement (BTA), targeted for finalisation by the end of the year.

'Economic blackmail': Rahul Gandhi slams Trump's 50 per cent tariff on India
'Economic blackmail': Rahul Gandhi slams Trump's 50 per cent tariff on India

New Indian Express

time4 minutes ago

  • New Indian Express

'Economic blackmail': Rahul Gandhi slams Trump's 50 per cent tariff on India

NEW DELHI: Leader of Opposition in Lok Sabha Rahul Gandhi on Wednesday said US President Donald Trump's 50 per cent tariff on Indian goods is "economic blackmail" to bully India into an unfair trade deal. Soon after Trump announced a penalty of another 25 per cent on India for buying Russian oil, the former Congress president said Prime Minister Narendra Modi should not let Indian interests be overridden. "Trump's 50% tariff is economic blackmail - an attempt to bully India into an unfair trade deal. "PM Modi better not let his weakness override the interests of the Indian people," Gandhi said in a post on X.

India Unites Against Trump's ‘ECONOMIC BLACKMAIL': PM Modi, Rahul Gandhi, Tharoor BLAST US Tariffs
India Unites Against Trump's ‘ECONOMIC BLACKMAIL': PM Modi, Rahul Gandhi, Tharoor BLAST US Tariffs

Time of India

time4 minutes ago

  • Time of India

India Unites Against Trump's ‘ECONOMIC BLACKMAIL': PM Modi, Rahul Gandhi, Tharoor BLAST US Tariffs

India's SHOCK Reply To Trump's 50% Tariffs; Fires 'Will PROTECT National Interests' Warning In a strongly worded statement, India's Ministry of External Affairs (MEA) sharply rejected the United States' new 25% tariff on Indian imports tied to Russian oil purchases—calling it 'unfair, unjustified, and unreasonable.' The MEA clarified that India's energy imports are driven by market dynamics and national interest, aimed at securing reliable, affordable energy for its 1.4 billion citizens. India noted that many other countries—including China, Turkey, and the EU—are also continuing trade with Russia, yet are not being targeted in the same way. 7.1K views | 1 hour ago

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store